Published in PLoS One on January 19, 2009
HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev (2011) 3.28
Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis (2011) 2.59
Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence. Pulm Med (2013) 1.98
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr (2011) 1.95
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med (2013) 1.91
Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med (2010) 1.08
QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. PLoS One (2012) 1.03
Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis. PLoS One (2011) 0.93
IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection. BMC Infect Dis (2010) 0.88
Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection. BMC Infect Dis (2011) 0.87
Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment. Clin Vaccine Immunol (2012) 0.87
Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test. BMC Infect Dis (2012) 0.84
Prognostic value of indeterminate IFN-γ release assay results in HIV-1 infection. J Clin Microbiol (2012) 0.83
Analysis of predictors influencing indeterminate whole-blood interferon-gamma release assay results in patients with rheumatic diseases. Rheumatol Int (2014) 0.81
Abnormalities in host defense associated with HIV infection. Clin Chest Med (2013) 0.81
The prevalence of latent Mycobacterium tuberculosis infection based on an interferon-γ release assay: a cross-sectional survey among urban adults in Mwanza, Tanzania. PLoS One (2013) 0.80
Stratified Threshold Values of QuantiFERON Assay for Diagnosing Tuberculosis Infection in Immunocompromised Populations. Tuberc Res Treat (2011) 0.80
In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis. Eur J Intern Med (2012) 0.75
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med (2008) 9.49
Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med (2007) 8.81
Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis (2004) 4.26
Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med (2006) 3.98
Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol (2001) 3.79
Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis (2000) 3.58
Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med (2006) 3.12
Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med (2008) 2.85
Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med (2006) 2.40
Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med (2008) 2.36
Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis (2007) 2.33
Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res (2006) 2.15
Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis (2006) 2.12
Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med (2007) 2.00
T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One (2008) 1.91
Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol (2006) 1.83
Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot. Eur Respir J (2007) 1.81
Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection (2007) 1.79
Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis (2004) 1.68
Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis. J Clin Microbiol (2007) 1.64
High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis (2008) 1.58
CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect (2007) 1.55
Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol (2008) 1.50
The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One (2008) 1.48
Risk for tuberculosis among children. Emerg Infect Dis (2006) 1.40
Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One (2008) 1.40
Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest (2008) 1.39
Recommendations of the Interim Policy on Collaborative TB/HIV activities. Wkly Epidemiol Rec (2004) 1.33
Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment. Int J Tuberc Lung Dis (2002) 1.33
Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis (2007) 1.25
Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol (2008) 1.20
Using tests for latent tuberculous infection to diagnose active tuberculosis: can we eat our cake and have it too? Ann Intern Med (2008) 1.17
A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int J Infect Dis (2008) 1.16
Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol (2007) 1.16
HIV and parasitic co-infections in tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. Ann Trop Med Parasitol (2007) 1.09
Clinical and radiological presentation of 340 adults with smear-positive tuberculosis in The Gambia. Int J Tuberc Lung Dis (2003) 1.07
Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis. Intern Med (2008) 1.04
Enhancement of diagnostic efficiency by a gamma interferon release assay for pulmonary tuberculosis. Clin Vaccine Immunol (2008) 0.92
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med (2008) 7.49
Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial. AIDS (2007) 3.51
Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis (2002) 3.22
Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS (2006) 3.03
Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS (2002) 2.93
Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol (2002) 2.83
Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS (2006) 2.83
Deep sequencing of the vaginal microbiota of women with HIV. PLoS One (2010) 2.59
Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis (2002) 2.39
Uptake of HIV voluntary counselling and testing services in rural Tanzania: implications for effective HIV prevention and equitable access to treatment. Trop Med Int Health (2008) 2.20
Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res (2006) 2.15
Point-of-care tests to strengthen health systems and save newborn lives: the case of syphilis. PLoS Med (2012) 2.13
Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial. PLoS Med (2010) 2.09
Hypothesis: Vitamin A supplementation and childhood mortality: amplification of the non-specific effects of vaccines? Int J Epidemiol (2003) 2.03
Patterned genital injury in cases of rape--a case-control study. J Forensic Leg Med (2013) 2.00
Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management. Drugs (2008) 1.95
Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results. Sex Transm Dis (2006) 1.91
Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study. J Infect Dis (2005) 1.88
Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol (2004) 1.81
HIV prevalence and incidence in rural Tanzania: results from 10 years of follow-up in an open-cohort study. J Acquir Immune Defic Syndr (2007) 1.81
Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed? Malar J (2007) 1.72
BCG vaccination status may predict sputum conversion in patients with pulmonary tuberculosis: a new consideration for an old vaccine? Thorax (2010) 1.69
Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr (2007) 1.69
Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial. J Infect Dis (2010) 1.67
Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania. Trop Med Int Health (2005) 1.64
Use of a clean delivery kit and factors associated with cord infection and puerperal sepsis in Mwanza, Tanzania. J Midwifery Womens Health (2007) 1.63
Association of schistosomiasis with false-positive HIV test results in an African adolescent population. J Clin Microbiol (2010) 1.59
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol (2013) 1.57
CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect (2007) 1.55
Obesity and regional fat distribution in Kenyan populations: impact of ethnicity and urbanization. Ann Hum Biol (2008) 1.53
Hormone replacement therapy increases the risk of cranial meningioma. Eur J Cancer (2013) 1.47
Trends in the uptake of voluntary counselling and testing for HIV in rural Tanzania in the context of the scale up of antiretroviral therapy. Trop Med Int Health (2012) 1.45
Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution. J Med Virol (2004) 1.42
Risk for tuberculosis among children. Emerg Infect Dis (2006) 1.40
Prevalence of substance abuse in pregnancy among Danish women. Acta Obstet Gynecol Scand (2014) 1.40
Microbicides development program, Tanzania-baseline characteristics of an occupational cohort and reattendance at 3 months. Sex Transm Dis (2007) 1.39
The MEMA kwa Vijana project: design of a community randomised trial of an innovative adolescent sexual health intervention in rural Tanzania. Contemp Clin Trials (2005) 1.39
Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One (2008) 1.39
A process evaluation of the scale up of a youth-friendly health services initiative in northern Tanzania. J Int AIDS Soc (2010) 1.39
Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PLoS One (2011) 1.39
Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis (2012) 1.38
Acceptability of medical male circumcision in the traditionally circumcising communities in Northern Tanzania. BMC Public Health (2011) 1.38
Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis (2007) 1.38
Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women. Am J Trop Med Hyg (2005) 1.38
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) (2011) 1.34
The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two-by-two factorial trial in Mwanza, Tanzania. Br J Nutr (2006) 1.32
IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res Notes (2009) 1.29
Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response. J Nutr (2008) 1.27
IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn (2012) 1.26
Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania. BMC Med (2012) 1.24
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med (2014) 1.22
A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine (2012) 1.22
Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial. Am J Trop Med Hyg (2007) 1.20
Prevention of gynecologic contact bleeding and genital sandy patches by childhood anti-schistosomal treatment. Am J Trop Med Hyg (2008) 1.20
Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One (2011) 1.19
Circumcision among adolescent boys in rural northwestern Tanzania. Trop Med Int Health (2008) 1.17
Evaluation of Mycobacterium tuberculosis--specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark. Clin Infect Dis (2007) 1.17
Schistosomiasis PCR in vaginal lavage as an indicator of genital Schistosoma haematobium infection in rural Zimbabwean women. Am J Trop Med Hyg (2009) 1.16
Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal. Bone (2003) 1.16
Earth-eating and reinfection with intestinal helminths among pregnant and lactating women in western Kenya. Trop Med Int Health (2005) 1.15
Schistosoma mansoni morbidity among adults in two villages along Lake Victoria shores in Mwanza District, Tanzania. Trans R Soc Trop Med Hyg (2008) 1.14
The epidemiology of HIV among young people in sub-Saharan Africa: know your local epidemic and its implications for prevention. J Adolesc Health (2011) 1.14
Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania. AIDS (2009) 1.14
The impact of antiretroviral therapy on adult mortality in rural Tanzania. Trop Med Int Health (2012) 1.13
The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomized controlled trial in Mwanza, Tanzania. Trop Med Int Health (2005) 1.11
Patient-centred tuberculosis treatment delivery under programmatic conditions in Tanzania: a cohort study. BMC Med (2009) 1.11
Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel. Trans R Soc Trop Med Hyg (2006) 1.10
Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settings. J Clin Microbiol (2009) 1.10
Dusty discos and dangerous desires: community perceptions of adolescent sexual and reproductive health risks and vulnerability and the potential role of parents in rural Mwanza, Tanzania. Cult Health Sex (2010) 1.10
Traditional male circumcision practices among the Kurya of North-eastern Tanzania and implications for national programmes. AIDS Care (2011) 1.10
Choice of foods and ingredients for moderately malnourished children 6 months to 5 years of age. Food Nutr Bull (2009) 1.09
Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm Bowel Dis (2011) 1.09
Perspectives in implementing standardized case definitions for tuberculosis research involving children in a low-income, high-burden setting. J Infect Dis (2012) 1.08
Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Mol Immunol (2006) 1.08
Survival after HIV infection in the pre-antiretroviral therapy era in a rural Tanzanian cohort. AIDS (2007) 1.07
Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases. J Rheumatol (2009) 1.07
Risk factors for unplanned pregnancy among young women in Tanzania. J Fam Plann Reprod Health Care (2013) 1.07
Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania. Contemp Clin Trials (2009) 1.06
Trends in HIV & syphilis prevalence and correlates of HIV infection: results from cross-sectional surveys among women attending ante-natal clinics in Northern Tanzania. BMC Public Health (2010) 1.06
Impact of the MEMA kwa Vijana adolescent sexual and reproductive health interventions on use of health services by young people in rural Mwanza, Tanzania: results of a cluster randomized trial. J Adolesc Health (2010) 1.05
Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes (2011) 1.04
Female genital schistosomiasis--a differential diagnosis to sexually transmitted disease: genital itch and vaginal discharge as indicators of genital Schistosoma haematobium morbidity in a cross-sectional study in endemic rural Zimbabwe. Trop Med Int Health (2008) 1.04
QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. PLoS One (2012) 1.03